Moneycontrol PRO

you are here: HomeNewsBusinessMarketsTeva offers to buy out Mylan: What does it mean for Natco

SHOW NAMES

Trending Topics

business

Teva offers to buy out Mylan: What does it mean for Natco

Natco is engaged in a legal battle to launch a generic version of Teva's top-selling drug Copaxone, patent on which expires in September.

first published: Apr 22, 2015 08:57 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Live: Sensex, Nifty fall 1% amidst broad-based selloff | Closing Bell
Live: Can Nifty reclaim record levels as investors await FOMC decision this week? | Opening Bell
Why This Tenant Says Bandra Is Better Than California | The Tenant
Nifty Clocks Triple-Digit Gains After RBI Rate Cut But Logs Losses For The Week| Closing Bell Live

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347